Next Article in Journal
Complementation Studies of Bacteriophage λ O Amber Mutants by Allelic Forms of O Expressed from Plasmid, and O-P Interaction Phenotypes
Next Article in Special Issue
The Cellular Mechanisms that Ensure an Efficient Secretion in Streptomyces
Previous Article in Journal
Engineering of Phage-Derived Lytic Enzymes: Improving Their Potential as Antimicrobials
Previous Article in Special Issue
Isolation, Characterization, and Antibacterial Activity of Hard-to-Culture Actinobacteria from Cave Moonmilk Deposits
Article Menu

Export Article

Open AccessReview
Antibiotics 2018, 7(2), 30; https://doi.org/10.3390/antibiotics7020030

Complex Regulatory Networks Governing Production of the Glycopeptide A40926

1
Department of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), Università degli Studi di Palermo, Viale delle Scienze Bd.16, 90128 Palermo, Italy
2
Via Ortles 22/4, Naicons Srl, 20139 Milano, Italy
3
Via Ortles 22/4, Ktedogen Srl, 20139 Milano, Italy
*
Author to whom correspondence should be addressed.
Received: 9 March 2018 / Revised: 29 March 2018 / Accepted: 3 April 2018 / Published: 5 April 2018
(This article belongs to the Special Issue Actinomycetes: The Antibiotics Producers)
View Full-Text   |   Download PDF [10617 KB, uploaded 3 May 2018]   |  

Abstract

Glycopeptides (GPAs) are an important class of antibiotics, with vancomycin and teicoplanin being used in the last 40 years as drugs of last resort to treat infections caused by Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus. A few new GPAs have since reached the market. One of them is dalbavancin, a derivative of A40926 produced by the actinomycete Nonomuraea sp. ATCC 39727, recently classified as N. gerenzanensis. This review summarizes what we currently know on the multilevel regulatory processes governing production of the glycopeptide A40926 and the different approaches used to increase antibiotic yields. Some nutrients, e.g., valine, l-glutamine and maltodextrin, and some endogenous proteins, e.g., Dbv3, Dbv4 and RpoBR, have a positive role on A40926 biosynthesis, while other factors, e.g., phosphate, ammonium and Dbv23, have a negative effect. Overall, the results available so far point to a complex regulatory network controlling A40926 in the native producing strain. View Full-Text
Keywords: glycopeptide antibiotics; dbv cluster; regulatory genes; StrR; LAL; LuxR solo; dalbavancin; A40926 glycopeptide antibiotics; dbv cluster; regulatory genes; StrR; LAL; LuxR solo; dalbavancin; A40926
Figures

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Alduina, R.; Sosio, M.; Donadio, S. Complex Regulatory Networks Governing Production of the Glycopeptide A40926. Antibiotics 2018, 7, 30.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Antibiotics EISSN 2079-6382 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top